EKF Diagnostics (LON:EKF – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported GBX 0.54 earnings per share for the quarter, Digital Look Earnings reports. EKF Diagnostics had a net margin of 4.86% and a return on equity of 3.58%.
EKF Diagnostics Stock Performance
LON EKF opened at GBX 26 on Thursday. The stock has a market capitalization of £111.32 million, a price-to-earnings ratio of 55.32 and a beta of 0.50. EKF Diagnostics has a twelve month low of GBX 22 and a twelve month high of GBX 31.70. The company has a current ratio of 4.72, a quick ratio of 1.77 and a debt-to-equity ratio of 2.09. The stock has a 50-day moving average of GBX 25.43 and a 200 day moving average of GBX 25.51.
About EKF Diagnostics
● Point-of-Care analysers in the key areas of Hematology and Diabetes
● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.
EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.
See Also
- Five stocks we like better than EKF Diagnostics
- This Gold ETF Turns a Non-Yielding Asset Into Monthly Income—But There’s a Catch
- Analysts See Double-Digit Upside for These 3 Stocks
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
